
Bristol-Myers Squibb Company (BMY)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
58.56 - Open
58.69 - Bid --
- Ask --
- Day's Range
57.27 - 58.88 - 52 Week Range
42.52 - 62.89 - Volume
11,330,228 - Avg. Volume
11,513,730 - Market Cap (intraday)
117.664B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
16.14 - EPS (TTM)
3.57 - Earnings Date Jul 30, 2026
- Forward Dividend & Yield 2.52 (4.37%)
- Ex-Dividend Date Jul 2, 2026
- 1y Target Est
63.08
Recent News
View MorePerformance Overview
Trailing total returns as of 6/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
117.66B
-
Enterprise Value
153.61B
-
Trailing P/E
16.14
-
Forward P/E
9.13
-
PEG Ratio (5yr expected)
1.50
-
Price/Sales (ttm)
2.43
-
Price/Book (mrq)
5.86
-
Enterprise Value/Revenue
3.17
-
Enterprise Value/EBITDA
10.24
Financial Highlights
Profitability and Income Statement
-
Profit Margin
15.01%
-
Return on Assets (ttm)
10.69%
-
Return on Equity (ttm)
38.73%
-
Revenue (ttm)
48.48B
-
Net Income Avi to Common (ttm)
7.27B
-
Diluted EPS (ttm)
3.57
Balance Sheet and Cash Flow
-
Total Cash (mrq)
10.49B
-
Total Debt/Equity (mrq)
230.97%
-
Levered Free Cash Flow (ttm)
9.85B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports
View More-
Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology, and cardiovascular conditions. BMY shares are a component of the S&P 500.
Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology, and cardiovascular conditions. BMY shares are a component of the S&P 500.
Rating -
The major indices are broadly higher at midday on Wednesday. Oil prices have plunged on optimism that a peace deal with Iran might be close. Crude oil is down 7% at $95 per barrel. The yield on the 10-year note is at 4.36%, and the VIX volatility index is at 17.
The major indices are broadly higher at midday on Wednesday. Oil prices have plunged on optimism that a peace deal with Iran might be close. Crude oil is down 7% at $95 per barrel. The yield on the 10-year note is at 4.36%, and the VIX volatility index is at 17.
-
Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology, and cardiovascular conditions. The company completed its merger with Celgene in November 2019. The BMY shares are a component of the S&P 500.
Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology, and cardiovascular conditions. The company completed its merger with Celgene in November 2019. The BMY shares are a component of the S&P 500.
Rating -
The war with Iran has entered its seventh week, with the ceasefire entering week two and a first round of peace talks having taken place over the weekend. On Wall Street, earnings season kicks off this week, with banks leading the charge. Last week, the Dow Jones Industrial Average was up 3%, the S&P 500 rose 4%, and the Nasdaq gained 5%. Year to date, all three indices are showing losses, with the Dow down 0.3%, the S&P lower by 0.4%, and the Nasdaq off by 1.5%. On the earnings calendar, Goldman Sachs reports on Monday; JPMorgan Chase, Citigroup, Wells Fargo, BlackRock, and Johnson & Johnson on Tuesday; Bank of America, Morgan Stanley, and PNC Financial on Wednesday; Taiwan Semiconductor, Netflix, PepsiCo, Abbott Labs, Charles Schwab, and Bank of New York Mellon on Thursday; and Truist Financial, Fifth Third Bank, and State Street on Friday. On the economic calendar, this is a light week. Existing Home Sales will be reported on Monday; the Producer Price Index is due out on Tuesday; and new data on Housing Starts and Building Permits hits the tape on Friday. The impact of the war is showing up in economic data. The price for gas jumped another 13 cents and is now at an average of $4.12 per gallon for regular gas. Atlanta Fed GDPNow now forecasts 1.3% growth for 1Q, down from 3.0% about a month ago. The Cleveland Fed Inflation Nowcast calls for CPI of 3.6% in April, up from the 3.3% print for March. Mortgage rates moved lower last week, down nine basis points last week, with the average 30-year fixed-rate mortgage now at 6.37%, according to FreddieMac. The next Federal Open Market Committee (FOMC) meeting is on April 29. Odds have pivoted from a rate cut to a rate hike, although the odds for a move of any kind are low at 2%. President Trump's nominee to be the next Fed chairman, Kevin Warsh, is continues to make his way through the Congressional approval process. After Jerome Powell's term as chairman expires, he will remain on the FOMC. Taking a deeper dive into performance so far in 2026, a leading industrialized global stock market index, the ETF EFA, is up 6% year to date. The leading emerging market ETF (EEM) is up 10% year to date. U.S. growth stocks are down 7% year to date, as per the ETF IWF, while value stocks (IWD) are up 5%. In other asset classes for the year to date, AGG bonds are down 1%, gold is up 10%, crude oil is up 66%, and Bitcoin is down 17%. The U.S. dollar is flat, tracking DXY. The VIX Volatility Index was about 19 on Friday, below its historical average of 20. Turning to sector performance, the list from first to worst so far in 2026 is Energy (+37%), Materials (+9%), Utilities (+8%), Consumer Staples (+7%), Industrials (+4%), Real Estate (+3%), Healthcare (-5%), Communication Services (-7%), Consumer Discretionary (-9%), Financials (-10%), and Information Technology (-12%). By comparison, the S&P 500 is down 0.4% year to date.
The war with Iran has entered its seventh week, with the ceasefire entering week two and a first round of peace talks having taken place over the weekend. On Wall Street, earnings season kicks off this week, with banks leading the charge. Last week, the Dow Jones Industrial Average was up 3%, the S&P 500 rose 4%, and the Nasdaq gained 5%. Year to date, all three indices are showing losses, with the Dow down 0.3%, the S&P lower by 0.4%, and the Nasdaq off by 1.5%. On the earnings calendar, Goldman Sachs reports on Monday; JPMorgan Chase, Citigroup, Wells Fargo, BlackRock, and Johnson & Johnson on Tuesday; Bank of America, Morgan Stanley, and PNC Financial on Wednesday; Taiwan Semiconductor, Netflix, PepsiCo, Abbott Labs, Charles Schwab, and Bank of New York Mellon on Thursday; and Truist Financial, Fifth Third Bank, and State Street on Friday. On the economic calendar, this is a light week. Existing Home Sales will be reported on Monday; the Producer Price Index is due out on Tuesday; and new data on Housing Starts and Building Permits hits the tape on Friday. The impact of the war is showing up in economic data. The price for gas jumped another 13 cents and is now at an average of $4.12 per gallon for regular gas. Atlanta Fed GDPNow now forecasts 1.3% growth for 1Q, down from 3.0% about a month ago. The Cleveland Fed Inflation Nowcast calls for CPI of 3.6% in April, up from the 3.3% print for March. Mortgage rates moved lower last week, down nine basis points last week, with the average 30-year fixed-rate mortgage now at 6.37%, according to FreddieMac. The next Federal Open Market Committee (FOMC) meeting is on April 29. Odds have pivoted from a rate cut to a rate hike, although the odds for a move of any kind are low at 2%. President Trump's nominee to be the next Fed chairman, Kevin Warsh, is continues to make his way through the Congressional approval process. After Jerome Powell's term as chairman expires, he will remain on the FOMC. Taking a deeper dive into performance so far in 2026, a leading industrialized global stock market index, the ETF EFA, is up 6% year to date. The leading emerging market ETF (EEM) is up 10% year to date. U.S. growth stocks are down 7% year to date, as per the ETF IWF, while value stocks (IWD) are up 5%. In other asset classes for the year to date, AGG bonds are down 1%, gold is up 10%, crude oil is up 66%, and Bitcoin is down 17%. The U.S. dollar is flat, tracking DXY. The VIX Volatility Index was about 19 on Friday, below its historical average of 20. Turning to sector performance, the list from first to worst so far in 2026 is Energy (+37%), Materials (+9%), Utilities (+8%), Consumer Staples (+7%), Industrials (+4%), Real Estate (+3%), Healthcare (-5%), Communication Services (-7%), Consumer Discretionary (-9%), Financials (-10%), and Information Technology (-12%). By comparison, the S&P 500 is down 0.4% year to date.









